4.6 (697) In stock
JAMA Internal Medicine study examines the safety of GLP-1 receptor agonists and other second-line antidiabetic medications during early pregnancy, finding no significant increase in congenital anomalies compared to insulin use.
What is GLP-1 & Does it Affect Weight & Cognition? - SelfHacked
Interaction with GLP-1 Receptors in the Brain and Gut
Traffic-related air pollution increases risk of hypertension in pregnant woman
Biomedicines, Free Full-Text
Sulfonylurea News, Research
Glucagon-like peptide 1 in health and disease
Review of FDA Approvals for Pediatric Obesity Management
The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury - ScienceDirect
FDA Approves Weight Loss Drug Wegovy for Teens
Comparison of adverse effects between GLP-1 receptor agonists.
Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force
Considerations about the role of GLP-1 receptor agonists in the
